Antibodies face the challenge against human respiratory syncytial virus
- PMID: 36634618
- DOI: 10.1016/j.chom.2022.12.010
Antibodies face the challenge against human respiratory syncytial virus
Abstract
In the December 22 issue of Cell, Bartsch et al. describe functional profiling of the antibody response to respiratory syncytial virus in human adults vaccinated with an experimental adenovirus-based prefusion-stabilized HRSV-F vaccine and subsequently intranasally challenged with HRSV. The authors identified various antibody effector functions as humoral correlates of protection.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment on
-
Antibody effector functions are associated with protection from respiratory syncytial virus.Cell. 2022 Dec 22;185(26):4873-4886.e10. doi: 10.1016/j.cell.2022.11.012. Epub 2022 Dec 12. Cell. 2022. PMID: 36513064
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
